Market Research Analysis United States Precision Medicine Market 2025 | Page 2

From the commercial aspect, the precision medicine poised as a clinical approach for disease prevention and
treatment taking into account an individual’s genes, lifestyle and environment prior to diagnosis. The market in United
States seems to deploy innovative tools for using massive datasets coupled with enhanced techniques for biomedical
analysis.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/united-states-precision-medicine-market/request-sample
Driving factors responsible for the growth of precision medicine industry in the United States includes rising rate of
cancer propelling the adoption of gene therapy enabling personalized treatment for patients based on their hereditary
factors. Rise in adoption of big data in healthcare and government initiatives to enhance healthcare infrastructure also
contributes to the market growth. Geographical segmentation for United States Precision Medicine Market includes
Southwest, The West, The Middle Atlantic, The South and The Midwest. North America dominates the market growth
owing to rise in government initiatives and rising geriatric population.
The key players in the United States Precision Medicine Market include Nano string Technologies, Ferrer inCode,
Covance, Silicon Biosystems, Almac Group Ltd, Pfizer, Laboratory Corporation of America Holdings and Novartis.
Market Segment:
Geographically, this report splits the United States market into seven regions:
• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
with sales (volume), revenue (value), market share and growth rate of Precision Medicine in these regions, from 2013
to 2025 (forecast).
United States Precision Medicine market competition by top manufacturers/players, with Precision Medicine sales
volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including